10-K Decoder · All companies

Cytokinetics, Incorporated

CYTK · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$88.0M$18.5M+377%
Operating income−$612M−$536M−14.2%
Net income−$785M−$590M−33.2%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026

$Q3 2026Year earlierChange
Revenue$47.6M$1.90M+2,405%
Operating income−$167M−$167M−0.2%
Net income−$190M−$306M+37.9%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Cytokinetics's revenue in FY2025?
$88.0M in FY2025 (Fiscal year ended Dec 31, 2025), +377% vs $18.5M a year earlier, per its 10-K filed Feb 2026.
Was Cytokinetics profitable in FY2025?
No: net income was −$785M and operating income −$612M in FY2025.
What was Cytokinetics's revenue in Q3 2026?
$47.6M (+2,405% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.